Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2025
[National Cancer Control in a Super-Aged Society-Based on the Fourth Basic Plan to Promote Cancer Control]Rika Kizawa, Genki Kanagawa, Aki Mukai, et al.
JCO Clinical Cancer Informatics|November 23, 2022
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-AnalysisYasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, et al.
Internal Medicine (Tokyo, Japan)|March 22, 2023
Granulocyte Colony-stimulating Factor-associated Aortitis on Gallium ScintigraphyHaruka Ozaki, Kohji Takemura, Rika Kizawa, et al.
Chemotherapy|October 11, 2023
Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct CarcinomaHiroki Okumura, Kyoko Murase, Suguru Oka, et al.
IJU Case Reports|March 6, 2023
Bell's palsy during rechallenge of immune checkpoint inhibitorKohji Takemura, Taro Yamanaka, Michikata Hayashida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Malignant Spinal Cord Compression]Yosuke Aoyama, Chihiro Kondoh, Masato Anno, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 9, 2024
Questionnaire survey of healthcare professionals on taxane-induced nail change in JapanKazumasa Yamamoto, Yuko Tanabe, Kiyomi Nonogaki, et al.
BMC Cancer|September 17, 2024
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancerTakayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
BRAF Mutation Heterogeneity Detected Using Circulating Tumor DNA Sequencing in Synchronous Colon Cancer: A Case ReportHaruka Kono, Taro Yamanaka, Yuki Nishihara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 4, 2025
Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trialRyohei Kawabata, Daisuke Sakai, Toshio Shimokawa, et al.
Pageof 2